Chemical Structure (Lubiprostone 01)
Lubiprostone Capsule, Gelatin Coated
Product Images NDC 43598-168
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 43598-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (8 mcg Capsule Bottle Label)
NDC 43598-163-60 Lubiprostone Capsules contains 60 capsules. Each soft gel capsule has 8 mcg of lubiprostone which is manufactured in Japan and encapsulated in the United States. It is distributed by Dr. Reddy's Laboratories and is for RxOnly. The package insert contains complete prescribing information, and it should be kept out of reach of children. The capsule should be swallowed whole and not chewed, broken apart. Dispense in a tightly closed, high-resistant container.*
Principal Display Panel (24 mcg Capsule Bottle Label)
It is a medication distributed by Dr. Reddy's and manufactured by Rostone Laboratories. The medication has 60 soft gel capsules containing 24 mcg of lubiprostone for swallowing whole, without breaking or chewing. The medication should be stored in a tightly closed, light-resistant container and kept out of reach of children. The package insert should be consulted for complete prescribing information. The ingredient is made in Japan and encapsulated in the United States. No readable information is present in the last line.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
